# Learning Personalized Treatment Decisions in Precision Medicine: Disentangling Treatment Assignment Bias in Counterfactual Outcome Prediction and Biomarker Identification

arXiv: https://arxiv.org/abs/2410.00509 · HTML: https://mlsanity.com/paper/2410.00509/

## Key facts

- Cited by 1 papers in the map (data through 14 Oct 2026).
- Builds on 11 of its 34 references that are in the map.
- First posted on arXiv 1 Oct 2024.

## Builds on (most cited first, 11 of 11)

- [A Unified Approach to Interpreting Model Predictions](https://mlsanity.com/paper/1705.07874/) (2017)
- [Meta-learners for Estimating Heterogeneous Treatment Effects using Machine Learning](https://mlsanity.com/paper/1706.03461/) (2017)
- [Causal Effect Inference with Deep Latent-Variable Models](https://mlsanity.com/paper/1705.08821/) (2017)
- [Learning Representations for Counterfactual Inference](https://mlsanity.com/paper/1605.03661/) (2016)
- [Adapting Neural Networks for the Estimation of Treatment Effects](https://mlsanity.com/paper/1906.02120/) (2019)
- [Nonparametric Estimation of Heterogeneous Treatment Effects: From Theory to Learning Algorithms](https://mlsanity.com/paper/2101.10943/) (2021)
- [The Case for Evaluating Causal Models Using Interventional Measures and Empirical Data](https://mlsanity.com/paper/1910.05387/) (2019)
- [Benchmarking Heterogeneous Treatment Effect Models through the Lens of Interpretability](https://mlsanity.com/paper/2206.08363/) (2022)
- [Generating Personalized Insulin Treatments Strategies with Deep Conditional Generative Time Series Models](https://mlsanity.com/paper/2309.16521/) (2023)
- [Defining Expertise: Applications to Treatment Effect Estimation](https://mlsanity.com/paper/2403.00694/) (2024)
- [Towards AI-Based Precision Oncology: A Machine Learning Framework for Personalized Counterfactual Treatment Suggestions based on Multi-Omics Data](https://mlsanity.com/paper/2402.12190/) (2024)

## Built on by (most cited first, 1 of 1)

- [Physiological World Models for Human State Transitions](https://mlsanity.com/paper/2608.15309/) (2026)

## Abstract (arXiv)

Precision medicine has the potential to tailor treatment decisions to individual patients using machine learning (ML) and artificial intelligence (AI), but it faces significant challenges due to complex biases in clinical observational data and the high-dimensional nature of biological data. This study models various types of treatment assignment biases using mutual information and investigates their impact on ML models for counterfactual prediction and biomarker identification. Unlike traditional counterfactual benchmarks that rely on fixed treatment policies, our work focuses on modeling different characteristics of the underlying observational treatment policy in distinct clinical settings. We validate our approach through experiments on toy datasets, semi-synthetic tumor cancer genome atlas (TCGA) data, and real-world biological outcomes from drug and CRISPR screens. By incorporating empirical biological mechanisms, we create a more realistic benchmark that reflects the complexities of real-world data. Our analysis reveals that different biases lead to varying model performances, with some biases, especially those unrelated to outcome mechanisms, having minimal effect on prediction accuracy. This highlights the crucial need to account for specific biases in clinical observational data in counterfactual ML model development, ultimately enhancing the personalization of treatment decisions in precision medicine.
